Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.
Taiwan J Obstet Gynecol
; 46(2): 146-51, 2007 Jun.
Article
in En
| MEDLINE
| ID: mdl-17638622
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Immunohistochemistry
/
In Situ Hybridization, Fluorescence
/
Receptor, ErbB-2
Limits:
Female
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Taiwan J Obstet Gynecol
Journal subject:
GINECOLOGIA
/
OBSTETRICIA
Year:
2007
Document type:
Article
Affiliation country:
Taiwan